KEQU has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
KEQU has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Research & Development is the aggregate amount of research and development expenses during the year. Kewaunee Scientific's Research & Development for the three months ended in Jul. 2024 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jul. 2024 was $0.0 Mil.
The historical data trend for Kewaunee Scientific's Research & Development can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kewaunee Scientific Annual Data | |||||||||||||||||||||
Trend | Apr15 | Apr16 | Apr17 | Apr18 | Apr19 | Apr20 | Apr21 | Apr22 | Apr23 | Apr24 | |||||||||||
Research & Development | Get a 7-Day Free Trial | - | - | - | - | - |
Kewaunee Scientific Quarterly Data | ||||||||||||||||||||
Oct19 | Jan20 | Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | Apr24 | Jul24 | |
Research & Development | Get a 7-Day Free Trial | - | - | - | - | - |
This is the expense the company spent on research and development.
Research & Development for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kewaunee Scientific (NAS:KEQU) Research & Development Explanation
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Thank you for viewing the detailed overview of Kewaunee Scientific's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.
Ryan S. Noble | officer: VP-Sales & Marketing-Americas | 2700 WEST FRONT STREET, STATESVILLE NC 28677 |
Mandar Ranade | officer: VP-Information Technology | 2700 WEST FRONT STREET, STATESVILLE NC 28677-2927 |
Elizabeth D Phillips | officer: VP - Human Resources | 2700 WEST FRONT STREET, STATESVILLE NC 28677 |
Douglas J. Batdorff | officer: VP of Manufacturing Operations | 2700 WEST FRONT STREET, STATESVILLE NC 28677 |
John Russell | director | 2331 MOHAWK LANE, GLENVIEW IL 60026 |
Hull Thomas David Iii | director, officer: President, CEO | 2700 WEST FRONT STREET, STATESVILLE NC 28677 |
Gardner Donald T. Iii | officer: Chief Financial Officer | 2700 WEST FRONT STREET, STATESVILLE NC 28677 |
Keith M Gehl | director | PO BOX 1017, CHARLOTTE NC 26201-1017 |
David Rhind | director | 1450 NORTH DEARBORN STREET, APT. 1A, CHICAGO IL 60610 |
Margaret B Pyle | director | 2700 WEST FRONT STREET, STATESVILLE NC 28677-2927 |
Donald F. Shaw | director | 662 EAST SUNBURST LANE, TEMPE AZ 85284-1599 |
Michael G. Rok | officer: VP of Manufacturing Operations | 2700 WEST FRONT STREET, STATESVILLE NC 28677-2927 |
Lisa L. Ryan | officer: VP-Construction/Cust. Servs. | 2700 WEST FRONT STREET, STATESVILLE NC 28677-2927 |
Kurt P Rindoks | officer: VP - Engineering/Prod. Dev. | 2700 WEST FRONT STREET, STATESVILLE NC 28677-2927 |
Bhoopathy Sathyamurthy | officer: VP-Managing Director-Int'l Ops | 2700 WEST FRONT STREET, STATESVILLE NC 28677-2927 |
From GuruFocus
By GuruFocus Research • 12-15-2023
By PRNewswire PRNewswire • 09-08-2021
By PRNewswire PRNewswire • 08-11-2021
By PRNewswire • 11-27-2024
By PRNewswire • 11-01-2024
By GuruFocus Research • 02-07-2024
By PRNewswire PRNewswire • 07-08-2021
By GuruFocus Research • 12-16-2023
By GuruFocus Research • 06-26-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.